Washington Reporter

Washington Reporter

Share this post

Washington Reporter
Washington Reporter
Op-Ed: Rep. Trey Gowdy: Patent proposals would be an early misstep for the new administration
Copy link
Facebook
Email
Notes
More
Editorials

Op-Ed: Rep. Trey Gowdy: Patent proposals would be an early misstep for the new administration

The Washington Reporter's avatar
The Washington Reporter
Nov 14, 2024

Share this post

Washington Reporter
Washington Reporter
Op-Ed: Rep. Trey Gowdy: Patent proposals would be an early misstep for the new administration
Copy link
Facebook
Email
Notes
More
Share
Washington Reporter

Quality patents have allowed large and small businesses in my home state of South Carolina and elsewhere to make critical breakthroughs in high-tech innovation. Whether it’s automobile manufacturing, health care technology, or software, inventors and businesses rely on a system that defends their inventions while also ensuring that low-quality patents don’t block competition or get leveraged against them in lawsuits.

That’s why businesses across the country have raised concerns about three pieces of proposed legislation — the Patent Eligibility Restoration Act (PERA), the Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act), and the Realizing Engineering, Science, and Technology Opportunities by Restoring Exclusive (RESTORE) Patent Rights Act. As President-elect Trump prepares to take office, these bills threaten America’s hard-won economic growth. 

For starters, PERA would reverse long-established judicial consensus by expanding what is patentable to include concepts that were previously considered too abstract to patent — concepts like naturally-occurring phenomena and genetic information. 

When the government grants a patent, it is, in essence, granting the owner a monopoly. If these monopolies become overly abstract, the outcome is decreased competition, increased litigation, and higher prices for consumers. Look no further than the pharmaceutical industry. PERA would make it easier for drug companies to keep prices artificially high by shrouding their products in webs of low-quality patent “thickets” which keep generic alternatives out of the marketplace. For Americans already struggling with the high costs of prescription drugs, this is a guaranteed way to make their economic lives more difficult.

Meanwhile, the PREVAIL Act proposes a series of changes which would make challenging invalid patents more difficult. When I entered Congress in 2011, I voted for the America Invents Act (AIA), a bipartisan reform to our patent system. The AIA created an expert review system at the U.S. Patent and Trademark Office (USPTO), where members of the public can challenge patents’ validity. These reviews resolve disputes more cheaply and efficiently than intellectual property lawsuits, allowing economic activity to continue unabated without bad actors in the patent system using patent infringement accusations for their own financial gain. But the PREVAIL Act would curtail access to USPTO review, allowing more broad and vague patent claims to be enforced despite their low quality, and in turn making it harder for inventors to operate in the competitive marketplace.

Lastly, the RESTORE Act would reverse unanimous precedent established in the Supreme Court’s 2006 decision in eBay v. MercExchange and presume injunctive relief across all patent infringement damages rulings. When injunctions are granted as a blanket practice, it allows bad actors to make massive settlement demands regardless of whether they have been wronged. 

Under the RESTORE Act, “patent trolls” — entities which produce nothing and exist only to sue others — can claim infringement on one minute component of a multi-part production process, and potentially shut down the manufacturing of an entire product indefinitely, if they get an injunction. Many manufacturers will capitulate to the trolls’ meritless settlement demands rather than put their facilities and workers’ futures at risk.

Maintaining and growing our economy means prioritizing American businesses and inventors, not litigation manipulators, competitors like China, or big Pharma, which benefit when patent quality and quality checks in our patent system are diminished. Moreover, while our fellow citizens are battling burgeoning inflation, millions of working and middle class Americans need a patent system that works for them, not companies who seem to profit regardless of whether average Americans are paying more for necessities like medicines.

As for the new Congress, new and returning members will soon find themselves facing competing priorities across committees and policy areas. For the sake of the American economy, members of the new Congress should focus on continuing pro-growth policies that protect our inventors and our intellectual property system, not on policies that will set back our innovation economy at this crucial juncture.

Trey Gowdy represented South Carolina’s 4th District in the U.S. House of Representatives from 2011-19. Prior to serving in Congress, he was a federal prosecutor and solicitor in South Carolina.


Subscribe to Washington Reporter

The intersection of policy and politics, with valuable insights straight from Hill staff and D.C. insiders.

Share this post

Washington Reporter
Washington Reporter
Op-Ed: Rep. Trey Gowdy: Patent proposals would be an early misstep for the new administration
Copy link
Facebook
Email
Notes
More
Share

Discussion about this post

User's avatar
Why the Biden Pill Penalty has been a disaster for Americans
A misguided policy enacted by former President Joe Biden has led to a 70 percent decline in investment in small-molecule drugs in the United States…
Mar 20 • 
The Washington Reporter
3

Share this post

Washington Reporter
Washington Reporter
Why the Biden Pill Penalty has been a disaster for Americans
Copy link
Facebook
Email
Notes
More
EXCLUSIVE: Multiple career intelligence staff confirm Biden admin DNI Avril Haines used Signal "all the time and on her personal phone"
Biden administration Director of National Intelligence (DNI) Avril Haines used Signal “all the time and on her personal phone,” according to multiple…
Apr 3 • 
Matthew Foldi
11

Share this post

Washington Reporter
Washington Reporter
EXCLUSIVE: Multiple career intelligence staff confirm Biden admin DNI Avril Haines used Signal "all the time and on her personal phone"
Copy link
Facebook
Email
Notes
More
Op-Ed: Rep. Mike Haridopolos: Take Donald Trump’s Greenland gambit seriously
President Donald Trump has the opportunity to make the deal of the century in the Arctic, Rep. Mike Haridopolos explains. Here's why it's needed.
Jan 10 • 
The Washington Reporter
14

Share this post

Washington Reporter
Washington Reporter
Op-Ed: Rep. Mike Haridopolos: Take Donald Trump’s Greenland gambit seriously
Copy link
Facebook
Email
Notes
More

Ready for more?

© 2025 Washington Reporter
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More

Create your profile

User's avatar

Only paid subscribers can comment on this post

Already a paid subscriber? Sign in

Check your email

For your security, we need to re-authenticate you.

Click the link we sent to , or click here to sign in.